5 Best Biotech Stocks to buy in February 2024

[{"selector":"#anim-eac04ddc-f881-4a17-9110-fb8fd6afb946","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] By : Sachin Gupta

Biocon has been trading around Rs.270.10 with an ROCE of 4.07% and ROE of 2.58%. The company has reported the OPM at 15.88%.

[{"selector":"#anim-fe331e5e-798b-44cd-9445-883ab413c95c [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-7dde056d-e43d-4aed-9db2-ab07ef327ecc","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

The company’s share is trading at around Rs. 492.05. Windlas’ ROCE and ROE are 14.17% and 10.59% respectively. While the OPM was 11.27%.

[{"selector":"#anim-24f1581f-9e72-4beb-8171-a46f91c31c58 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(1.8297793548266184%, 13.465349705367691%) scale(1.4464285714285714)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-49876126-07c0-40c1-9a1b-3c175b2f03ff","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

This subsidiary of Biocon is currently trading at around Rs. 743.15 with an ROCE of 13.75% and ROE of 12.83%. Syngene’s OPM is around 20.00%.

[{"selector":"#anim-d21c72ec-8428-4982-8ffc-122034926789 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(9.267948727305653e-15%, 6.393860954401325%) scale(1.434782608695652)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-9e74700e-e702-4f02-9ee0-993d75c36af7","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

[{"selector":"#anim-0d79cf94-5f01-48db-ae5c-dee1affdb347 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-d8114541-c7e7-40d8-b2df-0b62beed4dcb","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Vivo Biotech’s shares are trading at around Rs. 46.40 at present with ROCE and ROE of 12.51% and 5.10% while the OPM is noted at 23.49%.

[{"selector":"#anim-a14720bc-36d1-419e-8397-7441b43604af [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-ed6a7229-d57b-41c8-82ce-bea77715728e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Its share price is around Rs. 65.00. ANG Lifesciences’ ROCE, ROE, and OPM are 12.35%, -0.30%, and 6.59%, respectively.

Check out more 5paisa webstories

[{"selector":"#anim-2b940da1-b513-4b87-8c28-9244430c389b","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a7cd0f24-54dc-41b0-8007-acc18b400cb6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6fc905cc-1925-4345-9061-959ff8ede9a8","keyframes":{"transform":["translate3d(0px, 453.05562%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] More Web-Stories

[{"selector":"#anim-ec3d01cf-aac6-4e65-b285-34a9f7c67937","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8fe01510-ca3b-422d-a544-675af69d7271","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f7b7ceb9-6f79-4e73-960c-5d6fc65cc319","keyframes":{"transform":["translate3d(-120.06472%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Swipe up to Open Demat Account Click Here - Open Demat Account

5 Best Biotech Stocks to buy in February 2024

Published : 15 February 2024

Biocon has been trading around Rs.270.10 with an ROCE of 4.07% and ROE of 2.58%. The company has reported the OPM at 15.88%.

The company’s share is trading at around Rs. 492.05. Windlas’ ROCE and ROE are 14.17% and 10.59% respectively. While the OPM was 11.27%.

This subsidiary of Biocon is currently trading at around Rs. 743.15 with an ROCE of 13.75% and ROE of 12.83%. Syngene’s OPM is around 20.00%.

Check out more 5paisa webstories

Swipe up